Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. boosted the price target for Avadel Pharmaceuticals plc (NASDAQ:AVDL) from $21 to $25. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Avadel Pharmaceuticals shares gained 17.6% to close at $16.13 on Monday. See how other analysts view this stock.Barclays cut the price target for Noble Corporation plc (NYSE:NE) from $61 to $59. Barclays analyst Eddie Kim maintained an Overweight rating. Noble shares fell 0.8% to close at